1Landry GJ. Current medical and surgical management of Raynaud 's syndrome[ J]. J Vasc Surg,2013,57 (6) : 1710-1716.DOI : 10. 1016/j, j,ls. 2013.03. 012.
2Merritt WH. Role and rationale for extended periarterial sympa- thectomy in the management of severe Raynaud syndrome : tech- niques and results[J]. Hand Clin,2015,31 ( 1 ) : 101-120. DOI: 10. 1016/j. hcl. 2014.09.011.
3Yamada Y, Suzuki K, Nobata H, et al. Gemcitabine-induced he- molytic uremic syndrome mimicking scleroderma renal crisis pres- enting with Raynaud's phenomenon, positive antinuelear antibod- ies and hypertensive emergency[ J ]. Int Med,2014,53 (5) :445- 448.
4Chacon AH, Franca K, Ledon J, et al. Xerosis cutis : a common predicament of Raynaud "s disease [ J ]. Skinmed, 2014,12 ( 2 ) : 80 -82.
5Uppal L, Dhaliwal K, Butler PE. A prospective study of the use of botulinum toxin injections in the treatment of Raynand's syndrome associated with scleroderma [ J ]. J Hand Surg E.ur Vol, 2014,39 (8) :876-880. DOI: 10.1177/1753193413516242.
6Rosato E, Molinaro I, Rossi C, et al. The combination of laser Doppler perfusion imaging and photoplethysmography is useful in the characterization of scleroderma and primary Raynaud "s phe- nomenon[ J]. Scand J Rheumatol, 2011,40 ( 4 ) : 292-298. DOI : 10. 3109/03009742. 2010. 530293.
